UCP2 Gene Hyperinsulinism UCP2 related Genetic Test
Test Details
UCP2 gene hyperinsulinism refers to a genetic condition characterized by mutations in the UCP2 gene, which is responsible for producing a protein called uncoupling protein 2. This protein plays a role in regulating insulin secretion in the pancreas. Mutations in the UCP2 gene can lead to abnormal insulin secretion, resulting in hyperinsulinism. Hyperinsulinism is a condition characterized by excessive production and release of insulin, which can lead to low blood sugar levels (hypoglycemia).
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze an individual’s DNA and identify genetic mutations or variations. In the case of UCP2-related hyperinsulinism, NGS genetic testing can be used to identify specific mutations in the UCP2 gene that may be causing the condition. By identifying the specific genetic mutations involved, NGS genetic testing can help in diagnosing UCP2 gene hyperinsulinism and provide important information for personalized treatment and management of the condition. It can also be used for genetic counseling and family planning purposes, as it can help determine the risk of passing on the condition to future generations.
Test Name: UCP2 Gene Hyperinsulinism UCP2 related Genetic Test
Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
- Pre Test Information: Clinical History of Patient who is going for UCP2 Gene Hyperinsulinism, UCP2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperinsulinism, UCP2 related.
Test Name | UCP2 Gene Hyperinsulinism UCP2 related Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for UCP2 Gene Hyperinsulinism, UCP2 related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperinsulinism, UCP2 related |
Test Details |
UCP2 gene hyperinsulinism refers to a genetic condition characterized by mutations in the UCP2 gene, which is responsible for producing a protein called uncoupling protein 2. This protein plays a role in regulating insulin secretion in the pancreas. Mutations in the UCP2 gene can lead to abnormal insulin secretion, resulting in hyperinsulinism. Hyperinsulinism is a condition characterized by excessive production and release of insulin, which can lead to low blood sugar levels (hypoglycemia). NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze an individual’s DNA and identify genetic mutations or variations. In the case of UCP2-related hyperinsulinism, NGS genetic testing can be used to identify specific mutations in the UCP2 gene that may be causing the condition. By identifying the specific genetic mutations involved, NGS genetic testing can help in diagnosing UCP2 gene hyperinsulinism and provide important information for personalized treatment and management of the condition. It can also be used for genetic counseling and family planning purposes, as it can help determine the risk of passing on the condition to future generations. |